{
  "catalogId": "20b461b3-e4ba-47ad-82b7-dfc67b2933e7",
  "name": "DEXAMETHASONE KERN PHARMA",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "155 49 34117 00",
  "treatmentDescriptions": "Dexamethasone Kern Pharma is indicated in the treatment of:• Endocrine diseases such as nonsuppurative thyroiditis, hypercalcaemia associated with cancer and congenital adrenal hyperplasia.•  Allergy: Severe or disabling allergic conditions resistant to conventional treatments, as in: bronchial asthma, contact or atopical dermatitis, seasonal or perennial allergic rhinitis, hypersensitivity reactions to drugs.•  Ophtalmic: Serious inflammatory and allergic processes, acute and chronic, affecting the eyes, such as: iritis and iridocyclitis, chorioretinitis, choroiditis and diffuse posterior uveitis, optical neuritis, allergic conjunctivitis, allergic marginal corneal ulcers.•  Inflammatory Bowel dis.: Systemic treatment in exacerbations of ulcerative colitis and regional enteritis.•  Dermatological diseases (pemphigus, Stevens Johnson syndrome, exfoliative dermatitis, severe psoriasis and mycosis fungoides)       • Respiratory  diseases (symptomatic sarcoidosis, berylliosis, Loeffler's syndrome)• Haematological: acquired )autoimmune( haemolytic anaemia, idiopathic thrombocytopenic purpura in adult, pure red cell aplasia• Nephrotic syndrome of the idioplathic type or that due to lupus erythematosus• Cerebral edema caused by brain tumor, neurosurgery, brain abscess, bacterial meningitis• Collagen diseases: Active rheumatoid arthritis with severe progressive course, fast destructive remitting forms and / or extra-articular manifestations, Juvenile idiopathic arthritis with severe systemic-onset form (Still's disease) or locally with no control,  rheumatic fever with carditis, dermatomyositis, polymyositis, SLE, temporal arteritis.• Infectious Diseases: Bacterial meningitis – adjunct to antibiotics in suspected Pneumococcal meningitis and TB meningitis. Severe infectious diseases with toxic states (eg tuberculosis, typhoid, brucellosis;. Only with simultaneous anti-infective therapy)• Fetal lung maturation• Chemotherapy – associated nausea and vomiting• Multiple Myeloma – part of chemotherapy protocols (eg VAD)• Prevention and treatment of acute mountain sickness/HACE",
  "termsOfIssue": "Prescription required",
  "form": "solution for injection / infusion",
  "route": "i.v, i.m",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "DEXAMETHASONE PHOSPHATE ( AS SODIUM PHOSPHATE )/ML",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "H02AB02",
      "name": "DEXAMETHASONE"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה שאושרה לשימוש כללי בקופ'ח",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "DEXAMETHASONE KERN PHARMA 4MG/ML 3 AMP",
      "manufacturer": {
        "name": "אמ.בי.איי פארמה",
        "countryOfOrigin": "IL"
      },
      "strength": [],
      "quantity": {
        "value": 3.0,
        "unit": "units"
      },
      "packagingDescription": "AMPOULES GLASS TYPE I",
      "shelfLife": "30",
      "storageConditions": "",
      "codes": {
        "moh": "8973",
        "yarpa": "17073"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 14.79,
        "retailMargin": 37.0,
        "maxRetailPrice": 20.2623,
        "maxPriceWithVAT": 23.90951294
      },
      "formulation": ""
    }
  ],
  "metadata": {
    "version": "1.5",
    "lastUpdated": "2025-08-01T18:03:52.722762"
  }
}